This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: DPP-4 inhibitors

Dipeptidyl peptidase-4 (DPP-4) inhibitors

January 2017 Br J Cardiol 2017;24:(1) doi:10.5837/bjc.2017.001 Online First

Dipeptidyl peptidase-4 (DPP-4) inhibitors

Emma Johns, Gerry McKay, Miles Fisher

Abstract

(more…)

| Full text
Drugs for diabetes: part 5 DPP-4 inhibitors

June 2011 Br J Cardiol 2011;18:130–2

Drugs for diabetes: part 5 DPP-4 inhibitors

Claire McDougall, Gerard A McKay, Miles Fisher

Abstract

Introduction Type 2 diabetes, which is increasing in prevalence, is a major risk factor for cardiovascular morbidity and mortality. Although there are a number of pharmacological approaches to the management of type 2 diabetes, a large number of patients fail to reach glycaemic targets and a limited amount of drugs have shown benefit without glycaemic control. Therefore, there is still an unmet need in this therapeutic area. One recent advance in the management of type 2 diabetes has been the development and clinical use of dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists.1 The development of the

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now